0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538
Global Lung Cancer Liquid Biops Market Size, Status and Forecast 2020-2026
Published Date: March 2020
|
Report Code: QYRE-Auto-35Z1721
Home | Category |Business & Industrial |Pharmaceuticals & Biotech
Global Lung Cancer Liquid Biops Market Size Status and Forecast 2020 2026

Global Lung Cancer Liquid Biops Market Size, Status and Forecast 2020-2026

Code: QYRE-Auto-35Z1721
Report
March 2020
128 Pages
QYResearch
Region: Global, North America, Europe, Japan, Central & South America,
Description
Table of Content
Tables & Figures
This report focuses on the global Lung Cancer Liquid Biops status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lung Cancer Liquid Biops development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
    Biocept
    EntroGen
    Cynvenio Biosystems
    Exosome Diagnostics
    F. Hoffmann-La Roche
    Clearbridge BioMedics
    Bio-Rad Laboratories
    Agena Bioscience
    Cancer Genetics
    CellMax Life
    Nateras
    MedGenome
    OncoDNA
    Genomic Health
    Trovagene
    Fluxion Biosciences
    Biodesix
    Epic Sciences
    Shuwen Biotech
    Personal Genome Diagnostics
    Predicine
Market segment by Type, the product can be split into
    Exosomes and RNA
    CTCs and ctDNA
Market segment by Application, split into
    Hospitals and Clinics
    Physicians'office Laboratories
    Clinical Diagnostic Laboratories
Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America
The study objectives of this report are:
    To analyze global Lung Cancer Liquid Biops status, future forecast, growth opportunity, key market and key players.
    To present the Lung Cancer Liquid Biops development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Lung Cancer Liquid Biops are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lung Cancer Liquid Biops Revenue
1.4 Market Analysis by Type
1.4.1 Global Lung Cancer Liquid Biops Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Exosomes and RNA
1.4.3 CTCs and ctDNA
1.5 Market by Application
1.5.1 Global Lung Cancer Liquid Biops Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Physicians'office Laboratories
1.5.4 Clinical Diagnostic Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Lung Cancer Liquid Biops Market Perspective (2015-2026)
2.2 Lung Cancer Liquid Biops Growth Trends by Regions
2.2.1 Lung Cancer Liquid Biops Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lung Cancer Liquid Biops Historic Market Share by Regions (2015-2020)
2.2.3 Lung Cancer Liquid Biops Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Lung Cancer Liquid Biops Market Growth Strategy
2.3.6 Primary Interviews with Key Lung Cancer Liquid Biops Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Liquid Biops Players by Market Size
3.1.1 Global Top Lung Cancer Liquid Biops Players by Revenue (2015-2020)
3.1.2 Global Lung Cancer Liquid Biops Revenue Market Share by Players (2015-2020)
3.1.3 Global Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lung Cancer Liquid Biops Market Concentration Ratio
3.2.1 Global Lung Cancer Liquid Biops Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biops Revenue in 2019
3.3 Lung Cancer Liquid Biops Key Players Head office and Area Served
3.4 Key Players Lung Cancer Liquid Biops Product Solution and Service
3.5 Date of Enter into Lung Cancer Liquid Biops Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Lung Cancer Liquid Biops Historic Market Size by Type (2015-2020)
4.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Type (2021-2026)
5 Lung Cancer Liquid Biops Breakdown Data by Application (2015-2026)
5.1 Global Lung Cancer Liquid Biops Market Size by Application (2015-2020)
5.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Lung Cancer Liquid Biops Market Size (2015-2020)
6.2 Lung Cancer Liquid Biops Key Players in North America (2019-2020)
6.3 North America Lung Cancer Liquid Biops Market Size by Type (2015-2020)
6.4 North America Lung Cancer Liquid Biops Market Size by Application (2015-2020)
7 Europe
7.1 Europe Lung Cancer Liquid Biops Market Size (2015-2020)
7.2 Lung Cancer Liquid Biops Key Players in Europe (2019-2020)
7.3 Europe Lung Cancer Liquid Biops Market Size by Type (2015-2020)
7.4 Europe Lung Cancer Liquid Biops Market Size by Application (2015-2020)
8 China
8.1 China Lung Cancer Liquid Biops Market Size (2015-2020)
8.2 Lung Cancer Liquid Biops Key Players in China (2019-2020)
8.3 China Lung Cancer Liquid Biops Market Size by Type (2015-2020)
8.4 China Lung Cancer Liquid Biops Market Size by Application (2015-2020)
9 Japan
9.1 Japan Lung Cancer Liquid Biops Market Size (2015-2020)
9.2 Lung Cancer Liquid Biops Key Players in Japan (2019-2020)
9.3 Japan Lung Cancer Liquid Biops Market Size by Type (2015-2020)
9.4 Japan Lung Cancer Liquid Biops Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Lung Cancer Liquid Biops Market Size (2015-2020)
10.2 Lung Cancer Liquid Biops Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lung Cancer Liquid Biops Market Size by Type (2015-2020)
10.4 Southeast Asia Lung Cancer Liquid Biops Market Size by Application (2015-2020)
11 India
11.1 India Lung Cancer Liquid Biops Market Size (2015-2020)
11.2 Lung Cancer Liquid Biops Key Players in India (2019-2020)
11.3 India Lung Cancer Liquid Biops Market Size by Type (2015-2020)
11.4 India Lung Cancer Liquid Biops Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Lung Cancer Liquid Biops Market Size (2015-2020)
12.2 Lung Cancer Liquid Biops Key Players in Central & South America (2019-2020)
12.3 Central & South America Lung Cancer Liquid Biops Market Size by Type (2015-2020)
12.4 Central & South America Lung Cancer Liquid Biops Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Biocept
13.1.1 Biocept Company Details
13.1.2 Biocept Business Overview and Its Total Revenue
13.1.3 Biocept Lung Cancer Liquid Biops Introduction
13.1.4 Biocept Revenue in Lung Cancer Liquid Biops Business (2015-2020))
13.1.5 Biocept Recent Development
13.2 EntroGen
13.2.1 EntroGen Company Details
13.2.2 EntroGen Business Overview and Its Total Revenue
13.2.3 EntroGen Lung Cancer Liquid Biops Introduction
13.2.4 EntroGen Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.2.5 EntroGen Recent Development
13.3 Cynvenio Biosystems
13.3.1 Cynvenio Biosystems Company Details
13.3.2 Cynvenio Biosystems Business Overview and Its Total Revenue
13.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Introduction
13.3.4 Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.3.5 Cynvenio Biosystems Recent Development
13.4 Exosome Diagnostics
13.4.1 Exosome Diagnostics Company Details
13.4.2 Exosome Diagnostics Business Overview and Its Total Revenue
13.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Introduction
13.4.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.4.5 Exosome Diagnostics Recent Development
13.5 F. Hoffmann-La Roche
13.5.1 F. Hoffmann-La Roche Company Details
13.5.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
13.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Introduction
13.5.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.5.5 F. Hoffmann-La Roche Recent Development
13.6 Clearbridge BioMedics
13.6.1 Clearbridge BioMedics Company Details
13.6.2 Clearbridge BioMedics Business Overview and Its Total Revenue
13.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Introduction
13.6.4 Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.6.5 Clearbridge BioMedics Recent Development
13.7 Bio-Rad Laboratories
13.7.1 Bio-Rad Laboratories Company Details
13.7.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
13.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Introduction
13.7.4 Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.7.5 Bio-Rad Laboratories Recent Development
13.8 Agena Bioscience
13.8.1 Agena Bioscience Company Details
13.8.2 Agena Bioscience Business Overview and Its Total Revenue
13.8.3 Agena Bioscience Lung Cancer Liquid Biops Introduction
13.8.4 Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.8.5 Agena Bioscience Recent Development
13.9 Cancer Genetics
13.9.1 Cancer Genetics Company Details
13.9.2 Cancer Genetics Business Overview and Its Total Revenue
13.9.3 Cancer Genetics Lung Cancer Liquid Biops Introduction
13.9.4 Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.9.5 Cancer Genetics Recent Development
13.10 CellMax Life
13.10.1 CellMax Life Company Details
13.10.2 CellMax Life Business Overview and Its Total Revenue
13.10.3 CellMax Life Lung Cancer Liquid Biops Introduction
13.10.4 CellMax Life Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.10.5 CellMax Life Recent Development
13.11 Nateras
10.11.1 Nateras Company Details
10.11.2 Nateras Business Overview and Its Total Revenue
10.11.3 Nateras Lung Cancer Liquid Biops Introduction
10.11.4 Nateras Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.11.5 Nateras Recent Development
13.12 MedGenome
10.12.1 MedGenome Company Details
10.12.2 MedGenome Business Overview and Its Total Revenue
10.12.3 MedGenome Lung Cancer Liquid Biops Introduction
10.12.4 MedGenome Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.12.5 MedGenome Recent Development
13.13 OncoDNA
10.13.1 OncoDNA Company Details
10.13.2 OncoDNA Business Overview and Its Total Revenue
10.13.3 OncoDNA Lung Cancer Liquid Biops Introduction
10.13.4 OncoDNA Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.13.5 OncoDNA Recent Development
13.14 Genomic Health
10.14.1 Genomic Health Company Details
10.14.2 Genomic Health Business Overview and Its Total Revenue
10.14.3 Genomic Health Lung Cancer Liquid Biops Introduction
10.14.4 Genomic Health Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.14.5 Genomic Health Recent Development
13.15 Trovagene
10.15.1 Trovagene Company Details
10.15.2 Trovagene Business Overview and Its Total Revenue
10.15.3 Trovagene Lung Cancer Liquid Biops Introduction
10.15.4 Trovagene Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.15.5 Trovagene Recent Development
13.16 Fluxion Biosciences
10.16.1 Fluxion Biosciences Company Details
10.16.2 Fluxion Biosciences Business Overview and Its Total Revenue
10.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Introduction
10.16.4 Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.16.5 Fluxion Biosciences Recent Development
13.17 Biodesix
10.17.1 Biodesix Company Details
10.17.2 Biodesix Business Overview and Its Total Revenue
10.17.3 Biodesix Lung Cancer Liquid Biops Introduction
10.17.4 Biodesix Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.17.5 Biodesix Recent Development
13.18 Epic Sciences
10.18.1 Epic Sciences Company Details
10.18.2 Epic Sciences Business Overview and Its Total Revenue
10.18.3 Epic Sciences Lung Cancer Liquid Biops Introduction
10.18.4 Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.18.5 Epic Sciences Recent Development
13.19 Shuwen Biotech
10.19.1 Shuwen Biotech Company Details
10.19.2 Shuwen Biotech Business Overview and Its Total Revenue
10.19.3 Shuwen Biotech Lung Cancer Liquid Biops Introduction
10.19.4 Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.19.5 Shuwen Biotech Recent Development
13.20 Personal Genome Diagnostics
10.20.1 Personal Genome Diagnostics Company Details
10.20.2 Personal Genome Diagnostics Business Overview and Its Total Revenue
10.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Introduction
10.20.4 Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.20.5 Personal Genome Diagnostics Recent Development
13.21 Predicine
10.21.1 Predicine Company Details
10.21.2 Predicine Business Overview and Its Total Revenue
10.21.3 Predicine Lung Cancer Liquid Biops Introduction
10.21.4 Predicine Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.21.5 Predicine Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
    Table 1. Lung Cancer Liquid Biops Key Market Segments
    Table 2. Key Players Covered: Ranking by Lung Cancer Liquid Biops Revenue
    Table 3. Ranking of Global Top Lung Cancer Liquid Biops Manufacturers by Revenue (US$ Million) in 2019
    Table 4. Global Lung Cancer Liquid Biops Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
    Table 5. Key Players of Exosomes and RNA
    Table 6. Key Players of CTCs and ctDNA
    Table 7. Global Lung Cancer Liquid Biops Market Size Growth by Application (US$ Million): 2020 VS 2026
    Table 8. Global Lung Cancer Liquid Biops Market Size by Regions (US$ Million): 2020 VS 2026
    Table 9. Global Lung Cancer Liquid Biops Market Size by Regions (2015-2020) (US$ Million)
    Table 10. Global Lung Cancer Liquid Biops Market Share by Regions (2015-2020)
    Table 11. Global Lung Cancer Liquid Biops Forecasted Market Size by Regions (2021-2026) (US$ Million)
    Table 12. Global Lung Cancer Liquid Biops Market Share by Regions (2021-2026)
    Table 13. Market Top Trends
    Table 14. Key Drivers: Impact Analysis
    Table 15. Key Challenges
    Table 16. Lung Cancer Liquid Biops Market Growth Strategy
    Table 17. Main Points Interviewed from Key Lung Cancer Liquid Biops Players
    Table 18. Global Lung Cancer Liquid Biops Revenue by Players (2015-2020) (Million US$)
    Table 19. Global Lung Cancer Liquid Biops Market Share by Players (2015-2020)
    Table 20. Global Top Lung Cancer Liquid Biops Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Liquid Biops as of 2019)
    Table 21. Global Lung Cancer Liquid Biops by Players Market Concentration Ratio (CR5 and HHI)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Lung Cancer Liquid Biops Product Solution and Service
    Table 24. Date of Enter into Lung Cancer Liquid Biops Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Lung Cancer Liquid Biops Market Size by Type (2015-2020) (Million US$)
    Table 27. Global Lung Cancer Liquid Biops Market Size Share by Type (2015-2020)
    Table 28. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2021-2026)
    Table 29. Global Lung Cancer Liquid Biops Market Size Share by Application (2015-2020)
    Table 30. Global Lung Cancer Liquid Biops Market Size by Application (2015-2020) (Million US$)
    Table 31. Global Lung Cancer Liquid Biops Market Size Share by Application (2021-2026)
    Table 32. North America Key Players Lung Cancer Liquid Biops Revenue (2019-2020) (Million US$)
    Table 33. North America Key Players Lung Cancer Liquid Biops Market Share (2019-2020)
    Table 34. North America Lung Cancer Liquid Biops Market Size by Type (2015-2020) (Million US$)
    Table 35. North America Lung Cancer Liquid Biops Market Share by Type (2015-2020)
    Table 36. North America Lung Cancer Liquid Biops Market Size by Application (2015-2020) (Million US$)
    Table 37. North America Lung Cancer Liquid Biops Market Share by Application (2015-2020)
    Table 38. Europe Key Players Lung Cancer Liquid Biops Revenue (2019-2020) (Million US$)
    Table 39. Europe Key Players Lung Cancer Liquid Biops Market Share (2019-2020)
    Table 40. Europe Lung Cancer Liquid Biops Market Size by Type (2015-2020) (Million US$)
    Table 41. Europe Lung Cancer Liquid Biops Market Share by Type (2015-2020)
    Table 42. Europe Lung Cancer Liquid Biops Market Size by Application (2015-2020) (Million US$)
    Table 43. Europe Lung Cancer Liquid Biops Market Share by Application (2015-2020)
    Table 44. China Key Players Lung Cancer Liquid Biops Revenue (2019-2020) (Million US$)
    Table 45. China Key Players Lung Cancer Liquid Biops Market Share (2019-2020)
    Table 46. China Lung Cancer Liquid Biops Market Size by Type (2015-2020) (Million US$)
    Table 47. China Lung Cancer Liquid Biops Market Share by Type (2015-2020)
    Table 48. China Lung Cancer Liquid Biops Market Size by Application (2015-2020) (Million US$)
    Table 49. China Lung Cancer Liquid Biops Market Share by Application (2015-2020)
    Table 50. Japan Key Players Lung Cancer Liquid Biops Revenue (2019-2020) (Million US$)
    Table 51. Japan Key Players Lung Cancer Liquid Biops Market Share (2019-2020)
    Table 52. Japan Lung Cancer Liquid Biops Market Size by Type (2015-2020) (Million US$)
    Table 53. Japan Lung Cancer Liquid Biops Market Share by Type (2015-2020)
    Table 54. Japan Lung Cancer Liquid Biops Market Size by Application (2015-2020) (Million US$)
    Table 55. Japan Lung Cancer Liquid Biops Market Share by Application (2015-2020)
    Table 56. Southeast Asia Key Players Lung Cancer Liquid Biops Revenue (2019-2020) (Million US$)
    Table 57. Southeast Asia Key Players Lung Cancer Liquid Biops Market Share (2019-2020)
    Table 58. Southeast Asia Lung Cancer Liquid Biops Market Size by Type (2015-2020) (Million US$)
    Table 59. Southeast Asia Lung Cancer Liquid Biops Market Share by Type (2015-2020)
    Table 60. Southeast Asia Lung Cancer Liquid Biops Market Size by Application (2015-2020) (Million US$)
    Table 61. Southeast Asia Lung Cancer Liquid Biops Market Share by Application (2015-2020)
    Table 62. India Key Players Lung Cancer Liquid Biops Revenue (2019-2020) (Million US$)
    Table 63. India Key Players Lung Cancer Liquid Biops Market Share (2019-2020)
    Table 64. India Lung Cancer Liquid Biops Market Size by Type (2015-2020) (Million US$)
    Table 65. India Lung Cancer Liquid Biops Market Share by Type (2015-2020)
    Table 66. India Lung Cancer Liquid Biops Market Size by Application (2015-2020) (Million US$)
    Table 67. India Lung Cancer Liquid Biops Market Share by Application (2015-2020)
    Table 68. Central & South America Key Players Lung Cancer Liquid Biops Revenue (2019-2020) (Million US$)
    Table 69. Central & South America Key Players Lung Cancer Liquid Biops Market Share (2019-2020)
    Table 70. Central & South America Lung Cancer Liquid Biops Market Size by Type (2015-2020) (Million US$)
    Table 71. Central & South America Lung Cancer Liquid Biops Market Share by Type (2015-2020)
    Table 72. Central & South America Lung Cancer Liquid Biops Market Size by Application (2015-2020) (Million US$)
    Table 73. Central & South America Lung Cancer Liquid Biops Market Share by Application (2015-2020)
    Table 74. Biocept Company Details
    Table 75. Biocept Business Overview
    Table 76. Biocept Product
    Table 77. Biocept Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 78. Biocept Recent Development
    Table 79. EntroGen Company Details
    Table 80. EntroGen Business Overview
    Table 81. EntroGen Product
    Table 82. EntroGen Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 83. EntroGen Recent Development
    Table 84. Cynvenio Biosystems Company Details
    Table 85. Cynvenio Biosystems Business Overview
    Table 86. Cynvenio Biosystems Product
    Table 87. Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 88. Cynvenio Biosystems Recent Development
    Table 89. Exosome Diagnostics Company Details
    Table 90. Exosome Diagnostics Business Overview
    Table 91. Exosome Diagnostics Product
    Table 92. Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 93. Exosome Diagnostics Recent Development
    Table 94. F. Hoffmann-La Roche Company Details
    Table 95. F. Hoffmann-La Roche Business Overview
    Table 96. F. Hoffmann-La Roche Product
    Table 97. F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 98. F. Hoffmann-La Roche Recent Development
    Table 99. Clearbridge BioMedics Company Details
    Table 100. Clearbridge BioMedics Business Overview
    Table 101. Clearbridge BioMedics Product
    Table 102. Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 103. Clearbridge BioMedics Recent Development
    Table 104. Bio-Rad Laboratories Company Details
    Table 105. Bio-Rad Laboratories Business Overview
    Table 106. Bio-Rad Laboratories Product
    Table 107. Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 108. Bio-Rad Laboratories Recent Development
    Table 109. Agena Bioscience Business Overview
    Table 110. Agena Bioscience Product
    Table 111. Agena Bioscience Company Details
    Table 112. Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 113. Agena Bioscience Recent Development
    Table 114. Cancer Genetics Company Details
    Table 115. Cancer Genetics Business Overview
    Table 116. Cancer Genetics Product
    Table 117. Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 118. Cancer Genetics Recent Development
    Table 119. CellMax Life Company Details
    Table 120. CellMax Life Business Overview
    Table 121. CellMax Life Product
    Table 122. CellMax Life Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 123. CellMax Life Recent Development
    Table 124. Nateras Company Details
    Table 125. Nateras Business Overview
    Table 126. Nateras Product
    Table 127. Nateras Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 128. Nateras Recent Development
    Table 129. MedGenome Company Details
    Table 130. MedGenome Business Overview
    Table 131. MedGenome Product
    Table 132. MedGenome Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 133. MedGenome Recent Development
    Table 134. OncoDNA Company Details
    Table 135. OncoDNA Business Overview
    Table 136. OncoDNA Product
    Table 137. OncoDNA Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 138. OncoDNA Recent Development
    Table 139. Genomic Health Company Details
    Table 140. Genomic Health Business Overview
    Table 141. Genomic Health Product
    Table 142. Genomic Health Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 143. Genomic Health Recent Development
    Table 144. Trovagene Company Details
    Table 145. Trovagene Business Overview
    Table 146. Trovagene Product
    Table 147. Trovagene Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 148. Trovagene Recent Development
    Table 149. Fluxion Biosciences Company Details
    Table 150. Fluxion Biosciences Business Overview
    Table 151. Fluxion Biosciences Product
    Table 152. Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 153. Fluxion Biosciences Recent Development
    Table 154. Biodesix Company Details
    Table 155. Biodesix Business Overview
    Table 156. Biodesix Product
    Table 157. Biodesix Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 158. Biodesix Recent Development
    Table 159. Epic Sciences Company Details
    Table 160. Epic Sciences Business Overview
    Table 161. Epic Sciences Product
    Table 162. Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 163. Epic Sciences Recent Development
    Table 164. Shuwen Biotech Company Details
    Table 165. Shuwen Biotech Business Overview
    Table 166. Shuwen Biotech Product
    Table 167. Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 168. Shuwen Biotech Recent Development
    Table 169. Personal Genome Diagnostics Company Details
    Table 170. Personal Genome Diagnostics Business Overview
    Table 171. Personal Genome Diagnostics Product
    Table 172. Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 173. Personal Genome Diagnostics Recent Development
    Table 174. Predicine Company Details
    Table 175. Predicine Business Overview
    Table 176. Predicine Product
    Table 177. Predicine Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 178. Predicine Recent Development
    Table 179. Research Programs/Design for This Report
    Table 180. Key Data Information from Secondary Sources
    Table 181. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Lung Cancer Liquid Biops Market Share by Type: 2020 VS 2026
    Figure 2. Exosomes and RNA Features
    Figure 3. CTCs and ctDNA Features
    Figure 4. Global Lung Cancer Liquid Biops Market Share by Application: 2020 VS 2026
    Figure 5. Hospitals and Clinics Case Studies
    Figure 6. Physicians'office Laboratories Case Studies
    Figure 7. Clinical Diagnostic Laboratories Case Studies
    Figure 8. Lung Cancer Liquid Biops Report Years Considered
    Figure 9. Global Lung Cancer Liquid Biops Market Size YoY Growth 2015-2026 (US$ Million)
    Figure 10. Global Lung Cancer Liquid Biops Market Share by Regions: 2020 VS 2026
    Figure 11. Global Lung Cancer Liquid Biops Market Share by Regions (2021-2026)
    Figure 12. Porter's Five Forces Analysis
    Figure 13. Global Lung Cancer Liquid Biops Market Share by Players in 2019
    Figure 14. Global Top Lung Cancer Liquid Biops Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Liquid Biops as of 2019
    Figure 15. The Top 10 and 5 Players Market Share by Lung Cancer Liquid Biops Revenue in 2019
    Figure 16. North America Lung Cancer Liquid Biops Market Size YoY Growth (2015-2020) (Million US$)
    Figure 17. Europe Lung Cancer Liquid Biops Market Size YoY Growth (2015-2020) (Million US$)
    Figure 18. China Lung Cancer Liquid Biops Market Size YoY Growth (2015-2020) (Million US$)
    Figure 19. Japan Lung Cancer Liquid Biops Market Size YoY Growth (2015-2020) (Million US$)
    Figure 20. Southeast Asia Lung Cancer Liquid Biops Market Size YoY Growth (2015-2020) (Million US$)
    Figure 21. India Lung Cancer Liquid Biops Market Size YoY Growth (2015-2020) (Million US$)
    Figure 22. Central & South America Lung Cancer Liquid Biops Market Size YoY Growth (2015-2020) (Million US$)
    Figure 23. Biocept Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 24. Biocept Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 25. EntroGen Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 26. EntroGen Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 27. Cynvenio Biosystems Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 28. Cynvenio Biosystems Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 29. Exosome Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 30. Exosome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 31. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 32. F. Hoffmann-La Roche Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 33. Clearbridge BioMedics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 34. Clearbridge BioMedics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 35. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 36. Bio-Rad Laboratories Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 37. Agena Bioscience Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 38. Agena Bioscience Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 39. Cancer Genetics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 40. Cancer Genetics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 41. CellMax Life Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 42. CellMax Life Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 43. Nateras Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 44. Nateras Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 45. MedGenome Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 46. MedGenome Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 47. OncoDNA Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 48. OncoDNA Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 49. Genomic Health Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 50. Genomic Health Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 51. Trovagene Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 52. Trovagene Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 53. Fluxion Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 54. Fluxion Biosciences Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 55. Biodesix Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 56. Biodesix Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 57. Epic Sciences Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 58. Epic Sciences Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 59. Shuwen Biotech Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 60. Shuwen Biotech Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 61. Personal Genome Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 62. Personal Genome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
This report focuses on the global Lung Cancer Liquid Biops status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lung Cancer Liquid Biops development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
    Biocept
    EntroGen
    Cynvenio Biosystems
    Exosome Diagnostics
    F. Hoffmann-La Roche
    Clearbridge BioMedics
    Bio-Rad Laboratories
    Agena Bioscience
    Cancer Genetics
    CellMax Life
    Nateras
    MedGenome
    OncoDNA
    Genomic Health
    Trovagene
    Fluxion Biosciences
    Biodesix
    Epic Sciences
    Shuwen Biotech
    Personal Genome Diagnostics
    Predicine
Market segment by Type, the product can be split into
    Exosomes and RNA
    CTCs and ctDNA
Market segment by Application, split into
    Hospitals and Clinics
    Physicians'office Laboratories
    Clinical Diagnostic Laboratories
Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America
The study objectives of this report are:
    To analyze global Lung Cancer Liquid Biops status, future forecast, growth opportunity, key market and key players.
    To present the Lung Cancer Liquid Biops development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Lung Cancer Liquid Biops are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Read More
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lung Cancer Liquid Biops Revenue
1.4 Market Analysis by Type
1.4.1 Global Lung Cancer Liquid Biops Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Exosomes and RNA
1.4.3 CTCs and ctDNA
1.5 Market by Application
1.5.1 Global Lung Cancer Liquid Biops Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Physicians'office Laboratories
1.5.4 Clinical Diagnostic Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Lung Cancer Liquid Biops Market Perspective (2015-2026)
2.2 Lung Cancer Liquid Biops Growth Trends by Regions
2.2.1 Lung Cancer Liquid Biops Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lung Cancer Liquid Biops Historic Market Share by Regions (2015-2020)
2.2.3 Lung Cancer Liquid Biops Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Lung Cancer Liquid Biops Market Growth Strategy
2.3.6 Primary Interviews with Key Lung Cancer Liquid Biops Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Liquid Biops Players by Market Size
3.1.1 Global Top Lung Cancer Liquid Biops Players by Revenue (2015-2020)
3.1.2 Global Lung Cancer Liquid Biops Revenue Market Share by Players (2015-2020)
3.1.3 Global Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lung Cancer Liquid Biops Market Concentration Ratio
3.2.1 Global Lung Cancer Liquid Biops Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biops Revenue in 2019
3.3 Lung Cancer Liquid Biops Key Players Head office and Area Served
3.4 Key Players Lung Cancer Liquid Biops Product Solution and Service
3.5 Date of Enter into Lung Cancer Liquid Biops Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Lung Cancer Liquid Biops Historic Market Size by Type (2015-2020)
4.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Type (2021-2026)
5 Lung Cancer Liquid Biops Breakdown Data by Application (2015-2026)
5.1 Global Lung Cancer Liquid Biops Market Size by Application (2015-2020)
5.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Lung Cancer Liquid Biops Market Size (2015-2020)
6.2 Lung Cancer Liquid Biops Key Players in North America (2019-2020)
6.3 North America Lung Cancer Liquid Biops Market Size by Type (2015-2020)
6.4 North America Lung Cancer Liquid Biops Market Size by Application (2015-2020)
7 Europe
7.1 Europe Lung Cancer Liquid Biops Market Size (2015-2020)
7.2 Lung Cancer Liquid Biops Key Players in Europe (2019-2020)
7.3 Europe Lung Cancer Liquid Biops Market Size by Type (2015-2020)
7.4 Europe Lung Cancer Liquid Biops Market Size by Application (2015-2020)
8 China
8.1 China Lung Cancer Liquid Biops Market Size (2015-2020)
8.2 Lung Cancer Liquid Biops Key Players in China (2019-2020)
8.3 China Lung Cancer Liquid Biops Market Size by Type (2015-2020)
8.4 China Lung Cancer Liquid Biops Market Size by Application (2015-2020)
9 Japan
9.1 Japan Lung Cancer Liquid Biops Market Size (2015-2020)
9.2 Lung Cancer Liquid Biops Key Players in Japan (2019-2020)
9.3 Japan Lung Cancer Liquid Biops Market Size by Type (2015-2020)
9.4 Japan Lung Cancer Liquid Biops Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Lung Cancer Liquid Biops Market Size (2015-2020)
10.2 Lung Cancer Liquid Biops Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lung Cancer Liquid Biops Market Size by Type (2015-2020)
10.4 Southeast Asia Lung Cancer Liquid Biops Market Size by Application (2015-2020)
11 India
11.1 India Lung Cancer Liquid Biops Market Size (2015-2020)
11.2 Lung Cancer Liquid Biops Key Players in India (2019-2020)
11.3 India Lung Cancer Liquid Biops Market Size by Type (2015-2020)
11.4 India Lung Cancer Liquid Biops Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Lung Cancer Liquid Biops Market Size (2015-2020)
12.2 Lung Cancer Liquid Biops Key Players in Central & South America (2019-2020)
12.3 Central & South America Lung Cancer Liquid Biops Market Size by Type (2015-2020)
12.4 Central & South America Lung Cancer Liquid Biops Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Biocept
13.1.1 Biocept Company Details
13.1.2 Biocept Business Overview and Its Total Revenue
13.1.3 Biocept Lung Cancer Liquid Biops Introduction
13.1.4 Biocept Revenue in Lung Cancer Liquid Biops Business (2015-2020))
13.1.5 Biocept Recent Development
13.2 EntroGen
13.2.1 EntroGen Company Details
13.2.2 EntroGen Business Overview and Its Total Revenue
13.2.3 EntroGen Lung Cancer Liquid Biops Introduction
13.2.4 EntroGen Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.2.5 EntroGen Recent Development
13.3 Cynvenio Biosystems
13.3.1 Cynvenio Biosystems Company Details
13.3.2 Cynvenio Biosystems Business Overview and Its Total Revenue
13.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Introduction
13.3.4 Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.3.5 Cynvenio Biosystems Recent Development
13.4 Exosome Diagnostics
13.4.1 Exosome Diagnostics Company Details
13.4.2 Exosome Diagnostics Business Overview and Its Total Revenue
13.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Introduction
13.4.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.4.5 Exosome Diagnostics Recent Development
13.5 F. Hoffmann-La Roche
13.5.1 F. Hoffmann-La Roche Company Details
13.5.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
13.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Introduction
13.5.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.5.5 F. Hoffmann-La Roche Recent Development
13.6 Clearbridge BioMedics
13.6.1 Clearbridge BioMedics Company Details
13.6.2 Clearbridge BioMedics Business Overview and Its Total Revenue
13.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Introduction
13.6.4 Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.6.5 Clearbridge BioMedics Recent Development
13.7 Bio-Rad Laboratories
13.7.1 Bio-Rad Laboratories Company Details
13.7.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
13.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Introduction
13.7.4 Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.7.5 Bio-Rad Laboratories Recent Development
13.8 Agena Bioscience
13.8.1 Agena Bioscience Company Details
13.8.2 Agena Bioscience Business Overview and Its Total Revenue
13.8.3 Agena Bioscience Lung Cancer Liquid Biops Introduction
13.8.4 Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.8.5 Agena Bioscience Recent Development
13.9 Cancer Genetics
13.9.1 Cancer Genetics Company Details
13.9.2 Cancer Genetics Business Overview and Its Total Revenue
13.9.3 Cancer Genetics Lung Cancer Liquid Biops Introduction
13.9.4 Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.9.5 Cancer Genetics Recent Development
13.10 CellMax Life
13.10.1 CellMax Life Company Details
13.10.2 CellMax Life Business Overview and Its Total Revenue
13.10.3 CellMax Life Lung Cancer Liquid Biops Introduction
13.10.4 CellMax Life Revenue in Lung Cancer Liquid Biops Business (2015-2020)
13.10.5 CellMax Life Recent Development
13.11 Nateras
10.11.1 Nateras Company Details
10.11.2 Nateras Business Overview and Its Total Revenue
10.11.3 Nateras Lung Cancer Liquid Biops Introduction
10.11.4 Nateras Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.11.5 Nateras Recent Development
13.12 MedGenome
10.12.1 MedGenome Company Details
10.12.2 MedGenome Business Overview and Its Total Revenue
10.12.3 MedGenome Lung Cancer Liquid Biops Introduction
10.12.4 MedGenome Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.12.5 MedGenome Recent Development
13.13 OncoDNA
10.13.1 OncoDNA Company Details
10.13.2 OncoDNA Business Overview and Its Total Revenue
10.13.3 OncoDNA Lung Cancer Liquid Biops Introduction
10.13.4 OncoDNA Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.13.5 OncoDNA Recent Development
13.14 Genomic Health
10.14.1 Genomic Health Company Details
10.14.2 Genomic Health Business Overview and Its Total Revenue
10.14.3 Genomic Health Lung Cancer Liquid Biops Introduction
10.14.4 Genomic Health Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.14.5 Genomic Health Recent Development
13.15 Trovagene
10.15.1 Trovagene Company Details
10.15.2 Trovagene Business Overview and Its Total Revenue
10.15.3 Trovagene Lung Cancer Liquid Biops Introduction
10.15.4 Trovagene Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.15.5 Trovagene Recent Development
13.16 Fluxion Biosciences
10.16.1 Fluxion Biosciences Company Details
10.16.2 Fluxion Biosciences Business Overview and Its Total Revenue
10.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Introduction
10.16.4 Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.16.5 Fluxion Biosciences Recent Development
13.17 Biodesix
10.17.1 Biodesix Company Details
10.17.2 Biodesix Business Overview and Its Total Revenue
10.17.3 Biodesix Lung Cancer Liquid Biops Introduction
10.17.4 Biodesix Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.17.5 Biodesix Recent Development
13.18 Epic Sciences
10.18.1 Epic Sciences Company Details
10.18.2 Epic Sciences Business Overview and Its Total Revenue
10.18.3 Epic Sciences Lung Cancer Liquid Biops Introduction
10.18.4 Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.18.5 Epic Sciences Recent Development
13.19 Shuwen Biotech
10.19.1 Shuwen Biotech Company Details
10.19.2 Shuwen Biotech Business Overview and Its Total Revenue
10.19.3 Shuwen Biotech Lung Cancer Liquid Biops Introduction
10.19.4 Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.19.5 Shuwen Biotech Recent Development
13.20 Personal Genome Diagnostics
10.20.1 Personal Genome Diagnostics Company Details
10.20.2 Personal Genome Diagnostics Business Overview and Its Total Revenue
10.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Introduction
10.20.4 Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.20.5 Personal Genome Diagnostics Recent Development
13.21 Predicine
10.21.1 Predicine Company Details
10.21.2 Predicine Business Overview and Its Total Revenue
10.21.3 Predicine Lung Cancer Liquid Biops Introduction
10.21.4 Predicine Revenue in Lung Cancer Liquid Biops Business (2015-2020)
10.21.5 Predicine Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Read More
List of Tables
    Table 1. Lung Cancer Liquid Biops Key Market Segments
    Table 2. Key Players Covered: Ranking by Lung Cancer Liquid Biops Revenue
    Table 3. Ranking of Global Top Lung Cancer Liquid Biops Manufacturers by Revenue (US$ Million) in 2019
    Table 4. Global Lung Cancer Liquid Biops Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
    Table 5. Key Players of Exosomes and RNA
    Table 6. Key Players of CTCs and ctDNA
    Table 7. Global Lung Cancer Liquid Biops Market Size Growth by Application (US$ Million): 2020 VS 2026
    Table 8. Global Lung Cancer Liquid Biops Market Size by Regions (US$ Million): 2020 VS 2026
    Table 9. Global Lung Cancer Liquid Biops Market Size by Regions (2015-2020) (US$ Million)
    Table 10. Global Lung Cancer Liquid Biops Market Share by Regions (2015-2020)
    Table 11. Global Lung Cancer Liquid Biops Forecasted Market Size by Regions (2021-2026) (US$ Million)
    Table 12. Global Lung Cancer Liquid Biops Market Share by Regions (2021-2026)
    Table 13. Market Top Trends
    Table 14. Key Drivers: Impact Analysis
    Table 15. Key Challenges
    Table 16. Lung Cancer Liquid Biops Market Growth Strategy
    Table 17. Main Points Interviewed from Key Lung Cancer Liquid Biops Players
    Table 18. Global Lung Cancer Liquid Biops Revenue by Players (2015-2020) (Million US$)
    Table 19. Global Lung Cancer Liquid Biops Market Share by Players (2015-2020)
    Table 20. Global Top Lung Cancer Liquid Biops Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Liquid Biops as of 2019)
    Table 21. Global Lung Cancer Liquid Biops by Players Market Concentration Ratio (CR5 and HHI)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Lung Cancer Liquid Biops Product Solution and Service
    Table 24. Date of Enter into Lung Cancer Liquid Biops Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Lung Cancer Liquid Biops Market Size by Type (2015-2020) (Million US$)
    Table 27. Global Lung Cancer Liquid Biops Market Size Share by Type (2015-2020)
    Table 28. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2021-2026)
    Table 29. Global Lung Cancer Liquid Biops Market Size Share by Application (2015-2020)
    Table 30. Global Lung Cancer Liquid Biops Market Size by Application (2015-2020) (Million US$)
    Table 31. Global Lung Cancer Liquid Biops Market Size Share by Application (2021-2026)
    Table 32. North America Key Players Lung Cancer Liquid Biops Revenue (2019-2020) (Million US$)
    Table 33. North America Key Players Lung Cancer Liquid Biops Market Share (2019-2020)
    Table 34. North America Lung Cancer Liquid Biops Market Size by Type (2015-2020) (Million US$)
    Table 35. North America Lung Cancer Liquid Biops Market Share by Type (2015-2020)
    Table 36. North America Lung Cancer Liquid Biops Market Size by Application (2015-2020) (Million US$)
    Table 37. North America Lung Cancer Liquid Biops Market Share by Application (2015-2020)
    Table 38. Europe Key Players Lung Cancer Liquid Biops Revenue (2019-2020) (Million US$)
    Table 39. Europe Key Players Lung Cancer Liquid Biops Market Share (2019-2020)
    Table 40. Europe Lung Cancer Liquid Biops Market Size by Type (2015-2020) (Million US$)
    Table 41. Europe Lung Cancer Liquid Biops Market Share by Type (2015-2020)
    Table 42. Europe Lung Cancer Liquid Biops Market Size by Application (2015-2020) (Million US$)
    Table 43. Europe Lung Cancer Liquid Biops Market Share by Application (2015-2020)
    Table 44. China Key Players Lung Cancer Liquid Biops Revenue (2019-2020) (Million US$)
    Table 45. China Key Players Lung Cancer Liquid Biops Market Share (2019-2020)
    Table 46. China Lung Cancer Liquid Biops Market Size by Type (2015-2020) (Million US$)
    Table 47. China Lung Cancer Liquid Biops Market Share by Type (2015-2020)
    Table 48. China Lung Cancer Liquid Biops Market Size by Application (2015-2020) (Million US$)
    Table 49. China Lung Cancer Liquid Biops Market Share by Application (2015-2020)
    Table 50. Japan Key Players Lung Cancer Liquid Biops Revenue (2019-2020) (Million US$)
    Table 51. Japan Key Players Lung Cancer Liquid Biops Market Share (2019-2020)
    Table 52. Japan Lung Cancer Liquid Biops Market Size by Type (2015-2020) (Million US$)
    Table 53. Japan Lung Cancer Liquid Biops Market Share by Type (2015-2020)
    Table 54. Japan Lung Cancer Liquid Biops Market Size by Application (2015-2020) (Million US$)
    Table 55. Japan Lung Cancer Liquid Biops Market Share by Application (2015-2020)
    Table 56. Southeast Asia Key Players Lung Cancer Liquid Biops Revenue (2019-2020) (Million US$)
    Table 57. Southeast Asia Key Players Lung Cancer Liquid Biops Market Share (2019-2020)
    Table 58. Southeast Asia Lung Cancer Liquid Biops Market Size by Type (2015-2020) (Million US$)
    Table 59. Southeast Asia Lung Cancer Liquid Biops Market Share by Type (2015-2020)
    Table 60. Southeast Asia Lung Cancer Liquid Biops Market Size by Application (2015-2020) (Million US$)
    Table 61. Southeast Asia Lung Cancer Liquid Biops Market Share by Application (2015-2020)
    Table 62. India Key Players Lung Cancer Liquid Biops Revenue (2019-2020) (Million US$)
    Table 63. India Key Players Lung Cancer Liquid Biops Market Share (2019-2020)
    Table 64. India Lung Cancer Liquid Biops Market Size by Type (2015-2020) (Million US$)
    Table 65. India Lung Cancer Liquid Biops Market Share by Type (2015-2020)
    Table 66. India Lung Cancer Liquid Biops Market Size by Application (2015-2020) (Million US$)
    Table 67. India Lung Cancer Liquid Biops Market Share by Application (2015-2020)
    Table 68. Central & South America Key Players Lung Cancer Liquid Biops Revenue (2019-2020) (Million US$)
    Table 69. Central & South America Key Players Lung Cancer Liquid Biops Market Share (2019-2020)
    Table 70. Central & South America Lung Cancer Liquid Biops Market Size by Type (2015-2020) (Million US$)
    Table 71. Central & South America Lung Cancer Liquid Biops Market Share by Type (2015-2020)
    Table 72. Central & South America Lung Cancer Liquid Biops Market Size by Application (2015-2020) (Million US$)
    Table 73. Central & South America Lung Cancer Liquid Biops Market Share by Application (2015-2020)
    Table 74. Biocept Company Details
    Table 75. Biocept Business Overview
    Table 76. Biocept Product
    Table 77. Biocept Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 78. Biocept Recent Development
    Table 79. EntroGen Company Details
    Table 80. EntroGen Business Overview
    Table 81. EntroGen Product
    Table 82. EntroGen Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 83. EntroGen Recent Development
    Table 84. Cynvenio Biosystems Company Details
    Table 85. Cynvenio Biosystems Business Overview
    Table 86. Cynvenio Biosystems Product
    Table 87. Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 88. Cynvenio Biosystems Recent Development
    Table 89. Exosome Diagnostics Company Details
    Table 90. Exosome Diagnostics Business Overview
    Table 91. Exosome Diagnostics Product
    Table 92. Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 93. Exosome Diagnostics Recent Development
    Table 94. F. Hoffmann-La Roche Company Details
    Table 95. F. Hoffmann-La Roche Business Overview
    Table 96. F. Hoffmann-La Roche Product
    Table 97. F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 98. F. Hoffmann-La Roche Recent Development
    Table 99. Clearbridge BioMedics Company Details
    Table 100. Clearbridge BioMedics Business Overview
    Table 101. Clearbridge BioMedics Product
    Table 102. Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 103. Clearbridge BioMedics Recent Development
    Table 104. Bio-Rad Laboratories Company Details
    Table 105. Bio-Rad Laboratories Business Overview
    Table 106. Bio-Rad Laboratories Product
    Table 107. Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 108. Bio-Rad Laboratories Recent Development
    Table 109. Agena Bioscience Business Overview
    Table 110. Agena Bioscience Product
    Table 111. Agena Bioscience Company Details
    Table 112. Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 113. Agena Bioscience Recent Development
    Table 114. Cancer Genetics Company Details
    Table 115. Cancer Genetics Business Overview
    Table 116. Cancer Genetics Product
    Table 117. Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 118. Cancer Genetics Recent Development
    Table 119. CellMax Life Company Details
    Table 120. CellMax Life Business Overview
    Table 121. CellMax Life Product
    Table 122. CellMax Life Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 123. CellMax Life Recent Development
    Table 124. Nateras Company Details
    Table 125. Nateras Business Overview
    Table 126. Nateras Product
    Table 127. Nateras Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 128. Nateras Recent Development
    Table 129. MedGenome Company Details
    Table 130. MedGenome Business Overview
    Table 131. MedGenome Product
    Table 132. MedGenome Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 133. MedGenome Recent Development
    Table 134. OncoDNA Company Details
    Table 135. OncoDNA Business Overview
    Table 136. OncoDNA Product
    Table 137. OncoDNA Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 138. OncoDNA Recent Development
    Table 139. Genomic Health Company Details
    Table 140. Genomic Health Business Overview
    Table 141. Genomic Health Product
    Table 142. Genomic Health Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 143. Genomic Health Recent Development
    Table 144. Trovagene Company Details
    Table 145. Trovagene Business Overview
    Table 146. Trovagene Product
    Table 147. Trovagene Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 148. Trovagene Recent Development
    Table 149. Fluxion Biosciences Company Details
    Table 150. Fluxion Biosciences Business Overview
    Table 151. Fluxion Biosciences Product
    Table 152. Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 153. Fluxion Biosciences Recent Development
    Table 154. Biodesix Company Details
    Table 155. Biodesix Business Overview
    Table 156. Biodesix Product
    Table 157. Biodesix Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 158. Biodesix Recent Development
    Table 159. Epic Sciences Company Details
    Table 160. Epic Sciences Business Overview
    Table 161. Epic Sciences Product
    Table 162. Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 163. Epic Sciences Recent Development
    Table 164. Shuwen Biotech Company Details
    Table 165. Shuwen Biotech Business Overview
    Table 166. Shuwen Biotech Product
    Table 167. Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 168. Shuwen Biotech Recent Development
    Table 169. Personal Genome Diagnostics Company Details
    Table 170. Personal Genome Diagnostics Business Overview
    Table 171. Personal Genome Diagnostics Product
    Table 172. Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 173. Personal Genome Diagnostics Recent Development
    Table 174. Predicine Company Details
    Table 175. Predicine Business Overview
    Table 176. Predicine Product
    Table 177. Predicine Revenue in Lung Cancer Liquid Biops Business (2015-2020) (Million US$)
    Table 178. Predicine Recent Development
    Table 179. Research Programs/Design for This Report
    Table 180. Key Data Information from Secondary Sources
    Table 181. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Lung Cancer Liquid Biops Market Share by Type: 2020 VS 2026
    Figure 2. Exosomes and RNA Features
    Figure 3. CTCs and ctDNA Features
    Figure 4. Global Lung Cancer Liquid Biops Market Share by Application: 2020 VS 2026
    Figure 5. Hospitals and Clinics Case Studies
    Figure 6. Physicians'office Laboratories Case Studies
    Figure 7. Clinical Diagnostic Laboratories Case Studies
    Figure 8. Lung Cancer Liquid Biops Report Years Considered
    Figure 9. Global Lung Cancer Liquid Biops Market Size YoY Growth 2015-2026 (US$ Million)
    Figure 10. Global Lung Cancer Liquid Biops Market Share by Regions: 2020 VS 2026
    Figure 11. Global Lung Cancer Liquid Biops Market Share by Regions (2021-2026)
    Figure 12. Porter's Five Forces Analysis
    Figure 13. Global Lung Cancer Liquid Biops Market Share by Players in 2019
    Figure 14. Global Top Lung Cancer Liquid Biops Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Liquid Biops as of 2019
    Figure 15. The Top 10 and 5 Players Market Share by Lung Cancer Liquid Biops Revenue in 2019
    Figure 16. North America Lung Cancer Liquid Biops Market Size YoY Growth (2015-2020) (Million US$)
    Figure 17. Europe Lung Cancer Liquid Biops Market Size YoY Growth (2015-2020) (Million US$)
    Figure 18. China Lung Cancer Liquid Biops Market Size YoY Growth (2015-2020) (Million US$)
    Figure 19. Japan Lung Cancer Liquid Biops Market Size YoY Growth (2015-2020) (Million US$)
    Figure 20. Southeast Asia Lung Cancer Liquid Biops Market Size YoY Growth (2015-2020) (Million US$)
    Figure 21. India Lung Cancer Liquid Biops Market Size YoY Growth (2015-2020) (Million US$)
    Figure 22. Central & South America Lung Cancer Liquid Biops Market Size YoY Growth (2015-2020) (Million US$)
    Figure 23. Biocept Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 24. Biocept Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 25. EntroGen Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 26. EntroGen Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 27. Cynvenio Biosystems Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 28. Cynvenio Biosystems Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 29. Exosome Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 30. Exosome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 31. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 32. F. Hoffmann-La Roche Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 33. Clearbridge BioMedics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 34. Clearbridge BioMedics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 35. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 36. Bio-Rad Laboratories Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 37. Agena Bioscience Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 38. Agena Bioscience Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 39. Cancer Genetics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 40. Cancer Genetics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 41. CellMax Life Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 42. CellMax Life Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 43. Nateras Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 44. Nateras Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 45. MedGenome Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 46. MedGenome Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 47. OncoDNA Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 48. OncoDNA Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 49. Genomic Health Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 50. Genomic Health Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 51. Trovagene Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 52. Trovagene Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 53. Fluxion Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 54. Fluxion Biosciences Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 55. Biodesix Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 56. Biodesix Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 57. Epic Sciences Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 58. Epic Sciences Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 59. Shuwen Biotech Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 60. Shuwen Biotech Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 61. Personal Genome Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 62. Personal Genome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2015-2020)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI

RELATED REPORTS

COVID 19 Impact on Dermatophytosis Drugs Market Global Research Reports 2020 2021
COVID-19 Impact on Dermatophytosis Drugs Market, Global Research Reports 2020-2021

120 Pages
Type: Report
Code: QYRE-Auto-8R2876
Thu May 28 00:00:00 UTC 2020

Add to Cart

COVID 19 Impact on Drugs for Central Nervous System Market Global Research Reports 2020 2021
COVID-19 Impact on Drugs for Central Nervous System Market, Global Research Reports 2020-2021

120 Pages
Type: Report
Code: QYRE-Auto-25S2546
Thu May 28 00:00:00 UTC 2020

Add to Cart

COVID 19 Impact on Drugs for Anti Infective Market Global Research Reports 2020 2021
COVID-19 Impact on Drugs for Anti-Infective Market, Global Research Reports 2020-2021

120 Pages
Type: Report
Code: QYRE-Auto-23M2579
Thu May 28 00:00:00 UTC 2020

Add to Cart

COVID 19 Impact on Biochips Market Global Research Reports 2020 2021
COVID-19 Impact on Biochips Market, Global Research Reports 2020-2021

120 Pages
Type: Report
Code: QYRE-Auto-1O3049
Thu May 28 00:00:00 UTC 2020

Add to Cart

0 Items
X
No items in the cart.
$0.0